Loading…
Animal Drug and Animal Generic Drug User Fee Amendments of 2018
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
82pct
20d open
vs 3,805 other S bills in the 115th — cohort avg 41d
Animal Drug and Animal Generic Drug User Fee Amendments of 2018 This bill amends the Federal Food, Drug, and Cosmetic Act to reauthorize through FY2023 the collection of animal drug user fees.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (13)
Placed on Senate Legislative Calendar under General Orders. Calendar No. 341.
Committee on Health, Education, Labor, and Pensions. Reported by Senator Alexander with an amendment in the nature of a substitute. Without written report.
Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably.
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Introduced in Senate
Bills with similar content found using semantic analysis.
Sources: Congress.gov
2018 · fourth_quarter · Animals
Issues related to animal health, and food safety; antimicrobial resistance; HR 1587 Preservation of Antibiotics for Medical Treatment Act of 2017; S. 2434 and H.R. 5554, Animal Drug and Generic Animal Drug User Fee Act Amendments of 2018 and conditional approval
Client expense: $30,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE, U.S. Trade Representative (USTR)
2018 · fourth_quarter · Health Issues
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to companion labeling. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the repeal of the Affordable Care Act. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to FDA enforcement of prescription to over-the-counter switches of medicine. Monitor legislative and administrative action related to allowed purchases under the Supplemental Nutrition Assistance Program (SNAP). Monitor legislative and administrative action related to opioids. Monitor legislative and administrative action related to implementation of H.R. 3204, Drug Quality and Security Act. S. 404, A bill to amend the Federal Food, Drug, and Cosmetic Act to improve the process for inspections of device establishments and for granting export certifications. S. 469, Affordable and Safe Prescription Drug Importation Act. S. 934, FDA Reauthorization Act of 2017. S. 2434, Animal Drug and Animal Generic Drug User Fee Amendments Act of 2018. H.R. 749, Lower Drug Costs through Competition Act. H.R. 1628, American Health Care Act of 2017. H.R. 2009, To amend the Federal Food, Drug, and Cosmetic Act to provide clarity with respect to the regulation of diagnostic imaging devices intended for use with contrast agents. H.R. 2118, Medical Device Servicing Safety and Accountability Act. H.R. 2164, Medical Device Safety Act. H.R. 2430, FDA Reauthorization Act of 2017. H.R. 3841, SNAP Vitamin and Mineral Improvement Act of 2017. H.R. 3921, HEALTHY KIDS Act.
Client expense: $1,320,000 · Firm income: Not reported
2018 · fourth_quarter · Health Issues
Issues related to health care, the Food and Drug Administration (FDA), the 340B Program, animal health, drug pricing, oncology coverage, and direct-to-consumer (DTC) advertising; Vaccine provisions and TRICARE Pilot Program in H.R.5515/S.2987, National Defense Authorization Act for Fiscal Year 2019 (P.L.115-232); Implementation of P.L.114-255, 21st Century Cures Act; S.2434/H.R.5554, Animal Drug and Animal Generic Drug User Fee Amendments of 2018 (P.L.115-234); S.2852/H.R.6378, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018; H.R.6, SUPPORT for Patients and Communities Act (P.L.115-271); H.R.2/S.3042, Agriculture Improvement Act of 2018 (P.L.115-334); H.R.6642, To amend title XIX of the Social Security Act to sunset the limit on the maximum rebate amount for single source drugs and innovator multiple source drugs.
Client expense: Not reported · Firm income: $40,000
2018 · fourth_quarter · Animals
Issues related to animal health, veterinary medicine, antimicrobials, and food safety - no specific legislation; Issues related to the Animal Drug User Fee Act (ADUFA) S.2434/H.R.5554; Codex Alimentarius Commission (food safety, animal health), no specific legislation; Issues related to veterinary biologics, no specific legislation;
Client expense: $260,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
2018 · fourth_quarter · Telecommunications
Issues specific to wireless policy, including but not limited to spectrum policy, cyber security, privacy, data breach, infrastructure and tax related issues. S. 1104; Rural Wireless Access Act; H.R 3347 S. 1632, S. 1682, the AIRWAVES Act. S.2434, Precision Agriculture Connectivity Act, S. 2391, Defending U.S. Gov't Communications Act; S. 1988, SPEED Act; H.R. 6017 and S. 3010. the SPECTRUM NOW ACT.
Client expense: Not reported · Firm income: $68,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Security Council (NSC), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2018 · fourth_quarter · Health Issues
Issues related to Over the Counter (OTC) Monograph reform, influenza, and drug pricing; S.2852/H.R.6378, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018; S.2434/H.R.5554, Animal Drug and Animal Generic Drug User Fee Amendments of 2018 (P.L.115-234); S.2315, Over-the-Counter Drug Safety, Innovation, and Reform Act; H.R.5333, Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2018.
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · fourth_quarter · Health Issues
340B drug discount program; truthful non-misleading industry communications; compassionate use/right to try; importation of biopharmaceuticals; drug pricing; transparency; direct-to-consumer (DTC) advertising; H.R.2051, FAST Generics Act of 2017; TRICARE issues in H.R.5515/S.2987, National Defense Authorization Act for Fiscal Year 2019 (P.L.115-232); S.2434/H.R.5554, Animal Drug and Animal Generic Drug User Fee Amendments of 2018 (P.L.115-234); S.2852/H.R.6378, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018; H.R.6, SUPPORT for Patients and Communities Act (P.L.115-271); H.R.6642, To amend title XIX of the Social Security Act to sunset the limit on the maximum rebate amount for single source drugs and innovator multiple source drugs.
Client expense: Not reported · Firm income: $50,000
Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
2018 · fourth_quarter · Animals
Codex Alimentarius Commission (Animal Health Issues) Issues related to animal health and food safety - no specific legislation Implementation of biotechnology policy - no specific legislation Issues related to animal health, antibiotics, and food safety - no specific legislation Issues related to animal biologics - no specific legislation Issues related to antibiotics and medical treatment - no specific legislation Issues related to National Environmental Policy Act (implementing procedures - no specific legislation S.2434 - Animal Drug and Animal Generic Drug User Fee Amendments 2018
Client expense: Not reported · Firm income: $50,000
Government targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
2018 · fourth_quarter · Budget/Appropriations
S.2976/H.R.5961 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY'19 (APHIS and FDA) S.1839/H.R.2321 - CREAATE Act S.2434/H.R.5554 - Animal Drug and Animal Generic Drug User Fee Amendments of 2018
Client expense: Not reported · Firm income: $50,000
Government targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
2018 · fourth_quarter · Budget/Appropriations
S.2976/H.R.5961 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY'19 (APHIS and FDA) H.R.1625 - Consolidated Appropriations Act of 2018 (Antibiotics and Animal Health) - no specific legislation S.2434/H.R.5554 - Animal Drug and Animal Generic Drug User Fee Amendments of 2018
Client expense: Not reported · Firm income: $20,000
Government targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE
2018 · fourth_quarter · Animals
Issues related to animal health, antibiotics and food safety H.R.1587 - Preservation of Antibiotics for Medical Treatment Act of 2017 Issues related to National Environmental Policy Act Implementing Procedures - no specific legislation Implementation of biotechnology policy - no specific legislation S.2434 - Animal Drug & Animal Generic Drug User Fee Amendments 2018
Client expense: Not reported · Firm income: $20,000
Government targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE
2018 · fourth_quarter · Animals
Agricultural Improvement Act of 2018, S.3042/H.R. 2; Implementation of the Tax Cuts and Jobs Act; Issues related to animal health, veterinary medicine, antimicrobials, and food safety - no specific legislation; Issues related to the Animal Drug User Fee Act (ADUFA) S.2434/H.R. 5554; Codex Alimentarius Commission (food safety, animal health); Issues related to veterinary biologics - no specific legislation. Sanitary and phyto-sanitary (SPS) issues, no specific legislation; Food safety and public health, no specific legislation; Bilateral and multilateral trade negotiations, no specific legislation;
Client expense: Not reported · Firm income: Not reported
2018 · fourth_quarter · Trade (domestic/foreign)
Agricultural Improvement Act of 2018, S.3042/H.R. 2; Implementation of the Tax Cuts and Jobs Act; Issues related to animal health, veterinary medicine, antimicrobials, and food safety - no specific legislation; Issues related to the Animal Drug User Fee Act (ADUFA) S.2434/H.R. 5554; Codex Alimentarius Commission (food safety, animal health); Issues related to veterinary biologics - no specific legislation. Sanitary and phyto-sanitary (SPS) issues, no specific legislation; Food safety and public health, no specific legislation; Bilateral and multilateral trade negotiations, no specific legislation;
Client expense: Not reported · Firm income: Not reported
2018 · fourth_quarter · Food Industry (safety, labeling, etc.)
Agricultural Improvement Act of 2018, S.3042/H.R. 2; Implementation of the Tax Cuts and Jobs Act; Issues related to animal health, veterinary medicine, antimicrobials, and food safety - no specific legislation; Issues related to the Animal Drug User Fee Act (ADUFA) S.2434/H.R. 5554; Codex Alimentarius Commission (food safety, animal health); Issues related to veterinary biologics - no specific legislation. Sanitary and phyto-sanitary (SPS) issues, no specific legislation; Food safety and public health, no specific legislation; Bilateral and multilateral trade negotiations, no specific legislation;
Client expense: Not reported · Firm income: Not reported
2018 · fourth_quarter · Agriculture
Agricultural Improvement Act of 2018, S.3042/H.R. 2; Implementation of the Tax Cuts and Jobs Act; Issues related to animal health, veterinary medicine, antimicrobials, and food safety - no specific legislation; Issues related to the Animal Drug User Fee Act (ADUFA) S.2434/H.R. 5554; Codex Alimentarius Commission (food safety, animal health); Issues related to veterinary biologics - no specific legislation. Sanitary and phyto-sanitary (SPS) issues, no specific legislation; Food safety and public health, no specific legislation; Bilateral and multilateral trade negotiations, no specific legislation;
Client expense: Not reported · Firm income: Not reported
2018 · fourth_quarter · Health Issues
Agricultural Improvement Act of 2018, S.3042/H.R. 2; Implementation of the Tax Cuts and Jobs Act; Issues related to animal health, veterinary medicine, antimicrobials, and food safety - no specific legislation; Issues related to the Animal Drug User Fee Act (ADUFA) S.2434/H.R. 5554; Codex Alimentarius Commission (food safety, animal health); Issues related to veterinary biologics - no specific legislation. Sanitary and phyto-sanitary (SPS) issues, no specific legislation; Food safety and public health, no specific legislation; Bilateral and multilateral trade negotiations, no specific legislation;
Client expense: Not reported · Firm income: Not reported
2018 · fourth_quarter · Taxation/Internal Revenue Code
Agricultural Improvement Act of 2018, S.3042/H.R. 2; Implementation of the Tax Cuts and Jobs Act; Issues related to animal health, veterinary medicine, antimicrobials, and food safety - no specific legislation; Issues related to the Animal Drug User Fee Act (ADUFA) S.2434/H.R. 5554; Codex Alimentarius Commission (food safety, animal health); Issues related to veterinary biologics - no specific legislation. Sanitary and phyto-sanitary (SPS) issues, no specific legislation; Food safety and public health, no specific legislation; Bilateral and multilateral trade negotiations, no specific legislation;
Client expense: Not reported · Firm income: Not reported
2018 · fourth_quarter · Copyright/Patent/Trademark
Agricultural Improvement Act of 2018, S.3042/H.R. 2; Implementation of the Tax Cuts and Jobs Act; Issues related to animal health, veterinary medicine, antimicrobials, and food safety - no specific legislation; Issues related to the Animal Drug User Fee Act (ADUFA) S.2434/H.R. 5554; Codex Alimentarius Commission (food safety, animal health); Issues related to veterinary biologics - no specific legislation. Sanitary and phyto-sanitary (SPS) issues, no specific legislation; Food safety and public health, no specific legislation; Bilateral and multilateral trade negotiations, no specific legislation;
Client expense: Not reported · Firm income: Not reported
2018 · fourth_quarter · Animals
Animal Drug User Fee Act/Animal Generic User Fee Act S 2434, Animal Food Ingredient Amendments
Client expense: $20,000 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2018 · fourth_quarter · Trade (domestic/foreign)
Veterinary Feed Directive Implementation relating to CFR Part 11 Electronic Recordkeeping Requirements for VFDs, International Trade preservation and expansion related to preservation of NAFTA benefits and modernization, Animal Food Ingredient review and approval processes, Animal Drug User Fee Act and Animal Generic Drug User Fee Act S. 2434
Client expense: $20,000 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2018 · third_quarter · Animals
Issues related to animal health, and food safety; antimicrobial resistance; HR 1587 Preservation of Antibiotics for Medical Treatment Act of 2017; S. 2434 and H.R. 5554, Animal Drug and Generic Animal Drug User Fee Act Amendments of 2018 and conditional approval
Client expense: $30,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE, U.S. Trade Representative (USTR)
2018 · third_quarter · Telecommunications
Issues specific to wireless policy, including but not limited to spectrum policy, cyber security, privacy, data breach, infrastructure and tax related issues. S. 19, the Mobile Now Act, S. 1104; Rural Wireless Access Act; H.R 3347, Viewers Protection Act; S. 1632, Viewer and Listener Protection Act; S. 1682, the AIRWAVES Act. S.2434, Precision Agriculture Connectivity Act, HR 4881; S. 2391, Defending U.S. Gov't Communications Act; SJ Res 52, Resolution Reinstating Internet Freedom; S. 1988, SPEED Act; H.R. 6017 and S. 3010. the SPECTRUM NOW ACT
Client expense: Not reported · Firm income: $69,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · third_quarter · Pharmacy
H.R. 547/S. 2651 Fairness to Pet Owners Act H.R. 5554/S. 2434 Animal Drug and Animal Generic Drug User Fee Amendments of 2018; all provisions related to animal health and drug development H.R. 6, Support for Patients and Communities Act, provisions related to veterinary access to controlled substances for veterinary use, as prescribers and DEA registrants
Client expense: $220,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), SENATE, Transportation, Dept of (DOT)
2018 · third_quarter · Health Issues
Issues related to Over the Counter (OTC) Monograph reform, influenza, and drug pricing; S.2852, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018; H.R.6378, To reauthorize certain programs under the Pandemic and All-Hazards Preparedness Reauthorization Act; S.2434/H.R.5554, Animal Drug and Animal Generic Drug User Fee Amendments of 2018 (P.L.115-234); S.2315, Over-the-Counter Drug Safety, Innovation, and Reform Act; H.R.5333, Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2018.
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · third_quarter · Health Issues
340B drug discount program; truthful non-misleading industry communications; compassionate use/right to try; importation of biopharmaceuticals; drug pricing; transparency; direct-to-consumer (DTC) advertising; H.R.2051, FAST Generics Act of 2017; Implementation of P.L.115-176, Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017; TRICARE issues in H.R.5515/S.2987, National Defense Authorization Act for Fiscal Year 2019 (P.L.115-232); S.2434/H.R.5554, Animal Drug and Animal Generic Drug User Fee Amendments of 2018 (P.L.115-234); S.2852, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018; H.R.6378, To reauthorize certain programs under the Pandemic and All-Hazards Preparedness Reauthorization Act; H.R.6, SUPPORT for Patients and Communities Act.
Client expense: Not reported · Firm income: $50,000
Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
2018 · third_quarter · Animals
Codex Alimentarius Commission (Animal Health Issues) Issues related to animal health and food safety - no specific legislation Implementation of biotechnology policy - no specific legislation Issues related to animal health, antibiotics, and food safety - no specific legislation Issues related to animal biologics - no specific legislation Issues related to antibiotics and medical treatment - no specific legislation Issues related to National Environmental Policy Act (implementing procedures - no specific legislation S.2434 - Animal Drug and Animal Generic Drug User Fee Amendments 2018
Client expense: Not reported · Firm income: $50,000
Government targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
2018 · third_quarter · Budget/Appropriations
S.2976/H.R.5961 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY'19 (APHIS and FDA) S.1839/H.R.2321 - CREAATE Act S.2434/H.R.5554 - Animal Drug and Animal Generic Drug User Fee Amendments of 2018
Client expense: Not reported · Firm income: $50,000
Government targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
2018 · third_quarter · Budget/Appropriations
S.2976/H.R.5961 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY'19 (APHIS, FDA, and Foreign Market Development Program) H.R.1625 - Consolidated Appropriations Act of 2018 (Antibiotics and Animal Health) - no specific legislation S.2434/H.R.5554 - Animal Drug and Animal Generic Drug User Fee Amendments of 2018
Client expense: Not reported · Firm income: $20,000
Government targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE
2018 · third_quarter · Animals
Issues related to animal health, antibiotics and food safety H.R.1587 - Preservation of Antibiotics for Medical Treatment Act of 2017 Issues related to National Environmental Policy Act Implementing Procedures - no specific legislation Implementation of biotechnology policy - no specific legislation S.2434 - Animal Drug & Animal Generic Drug User Fee Amendments 2018
Client expense: Not reported · Firm income: $20,000
Government targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE
2018 · second_quarter · Health Issues
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to companion labeling. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the repeal of the Affordable Care Act. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to FDA enforcement of prescription to over-the-counter switches of medicine. Monitor legislative and administrative action related to allowed purchases under the Supplemental Nutrition Assistance Program (SNAP). Monitor legislative and administrative action related to opioids. Monitor legislative and administrative action related to implementation of H.R. 3204, Drug Quality and Security Act. S. 404, A bill to amend the Federal Food, Drug, and Cosmetic Act to improve the process for inspections of device establishments and for granting export certifications. S. 469, Affordable and Safe Prescription Drug Importation Act. S. 934, FDA Reauthorization Act of 2017. S. 2434, Animal Drug and Animal Generic Drug User Fee Amendments Act of 2018. H.R. 749, Lower Drug Costs through Competition Act. H.R. 1628, American Health Care Act of 2017. H.R. 2009, To amend the Federal Food, Drug, and Cosmetic Act to provide clarity with respect to the regulation of diagnostic imaging devices intended for use with contrast agents. H.R. 2118, Medical Device Servicing Safety and Accountability Act. H.R. 2164, Medical Device Safety Act. H.R. 2430, FDA Reauthorization Act of 2017. H.R. 3841, SNAP Vitamin and Mineral Improvement Act of 2017. H.R. 3921, HEALTHY KIDS Act.
Client expense: $1,700,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Security Council (NSC), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
2018 · third_quarter · Health Issues
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to companion labeling. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the repeal of the Affordable Care Act. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to FDA enforcement of prescription to over-the-counter switches of medicine. Monitor legislative and administrative action related to allowed purchases under the Supplemental Nutrition Assistance Program (SNAP). Monitor legislative and administrative action related to opioids. Monitor legislative and administrative action related to implementation of H.R. 3204, Drug Quality and Security Act. S. 404, A bill to amend the Federal Food, Drug, and Cosmetic Act to improve the process for inspections of device establishments and for granting export certifications. S. 469, Affordable and Safe Prescription Drug Importation Act. S. 934, FDA Reauthorization Act of 2017. S. 2434, Animal Drug and Animal Generic Drug User Fee Amendments Act of 2018. H.R. 749, Lower Drug Costs through Competition Act. H.R. 1628, American Health Care Act of 2017. H.R. 2009, To amend the Federal Food, Drug, and Cosmetic Act to provide clarity with respect to the regulation of diagnostic imaging devices intended for use with contrast agents. H.R. 2118, Medical Device Servicing Safety and Accountability Act. H.R. 2164, Medical Device Safety Act. H.R. 2430, FDA Reauthorization Act of 2017. H.R. 3841, SNAP Vitamin and Mineral Improvement Act of 2017. H.R. 3921, HEALTHY KIDS Act.
Client expense: $1,600,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Security Council (NSC), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
2018 · third_quarter · Pharmacy
H.R. 547/S. 2651 Fairness to Pet Owners Act H.R. 5554/S. 2434 Animal Drug and Animal Generic Drug User Fee Amendments of 2018; all provisions related to animal health and drug development H.R. 6, Support for Patients and Communities Act, provisions related to veterinary access to controlled substances for veterinary use, as prescribers and DEA registrants
Client expense: $220,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), SENATE, Transportation, Dept of (DOT)
2018 · third_quarter · Health Issues
Issues related to health care, the Food and Drug Administration (FDA), the 340B Program, animal health, drug pricing, oncology coverage, and direct-to-consumer (DTC) advertising; Vaccine provisions and TRICARE Pilot Program in H.R.5515/S.2987, National Defense Authorization Act for Fiscal Year 2019 (P.L.115-232); Implementation of P.L.114-255, 21st Century Cures Act; Implementation of P.L.115-176, Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017; S.2434/H.R.5554, Animal Drug and Animal Generic Drug User Fee Amendments of 2018 (P.L.115-234); S.2852, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018; H.R.6378, To reauthorize certain programs under the Pandemic and All-Hazards Preparedness Reauthorization Act; H.R.6, SUPPORT for Patients and Communities Act.
Client expense: Not reported · Firm income: $40,000
Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
2018 · third_quarter · Trade (domestic/foreign)
Veterinary Feed Directive Implementation relating to CFR Part 11 Electronic Recordkeeping Requirements for VFDs, International Trade preservation and expansion related to preservation of NAFTA benefits and modernization, Animal Food Ingredient review and approval processes, Animal Drug User Fee Act and Animal Generic Drug User Fee Act S. 2434
Client expense: $20,000 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2018 · third_quarter · Animals
Animal Drug User Fee Act/Animal Generic User Fee Act S 2434, Animal Food Ingredient Amendments
Client expense: $20,000 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2018 · second_quarter · Animals
Issues related to animal health, and food safety; antimicrobial resistance; HR 1587 Preservation of Antibiotics for Medical Treatment Act of 2017; S. 2434 and H.R. 5554, Animal Drug and Generic Animal Drug User Fee Act Amendments of 2018 and conditional approval
Client expense: $45,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE, U.S. Trade Representative (USTR)
2018 · second_quarter · Health Issues
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to companion labeling. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the repeal of the Affordable Care Act. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to FDA enforcement of prescription to over-the-counter switches of medicine. Monitor legislative and administrative action related to allowed purchases under the Supplemental Nutrition Assistance Program (SNAP). Monitor legislative and administrative action related to opioids. Monitor legislative and administrative action related to implementation of H.R. 3204, Drug Quality and Security Act. S. 404, A bill to amend the Federal Food, Drug, and Cosmetic Act to improve the process for inspections of device establishments and for granting export certifications. S. 469, Affordable and Safe Prescription Drug Importation Act. S. 934, FDA Reauthorization Act of 2017. S. 2434, Animal Drug and Animal Generic Drug User Fee Amendments Act of 2018. H.R. 749, Lower Drug Costs through Competition Act. H.R. 1628, American Health Care Act of 2017. H.R. 2009, To amend the Federal Food, Drug, and Cosmetic Act to provide clarity with respect to the regulation of diagnostic imaging devices intended for use with contrast agents. H.R. 2118, Medical Device Servicing Safety and Accountability Act. H.R. 2164, Medical Device Safety Act. H.R. 2430, FDA Reauthorization Act of 2017. H.R. 3841, SNAP Vitamin and Mineral Improvement Act of 2017. H.R. 3921, HEALTHY KIDS Act.
Client expense: $1,670,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Security Council (NSC), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
2018 · first_quarter · Health Issues
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to companion labeling. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the repeal of the Affordable Care Act. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to FDA enforcement of prescription to over-the-counter switches of medicine. Monitor legislative and administrative action related to allowed purchases under the Supplemental Nutrition Assistance Program (SNAP). Monitor legislative and administrative action related to opioids. Monitor legislative and administrative action related to implementation of H.R. 3204, Drug Quality and Security Act. S. 404, A bill to amend the Federal Food, Drug, and Cosmetic Act to improve the process for inspections of device establishments and for granting export certifications. S. 469, Affordable and Safe Prescription Drug Importation Act. S. 934, FDA Reauthorization Act of 2017. S. 2434, Animal Drug and Animal Generic Drug User Fee Amendments Act of 2018. H.R. 749, Lower Drug Costs through Competition Act. H.R. 1628, American Health Care Act of 2017. H.R. 2009, To amend the Federal Food, Drug, and Cosmetic Act to provide clarity with respect to the regulation of diagnostic imaging devices intended for use with contrast agents. H.R. 2118, Medical Device Servicing Safety and Accountability Act. H.R. 2164, Medical Device Safety Act. H.R. 2430, FDA Reauthorization Act of 2017. H.R. 3841, SNAP Vitamin and Mineral Improvement Act of 2017. H.R. 3921, HEALTHY KIDS Act.
Client expense: $3,420,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Security Council (NSC), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
2018 · second_quarter · Animals
Issues related to animal health, antibiotics and food safety H.R.1587 - Preservation of Antibiotics for Medical Treatment Act of 2017 Issues related to National Environmental Policy Act Implementing Procedures - no specific legislation Implementation of biotechnology policy - no specific legislation S.2434 - Animal Drug & Animal Generic Drug User Fee Amendments 2018
Client expense: Not reported · Firm income: $20,000
Government targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE
2018 · second_quarter · Budget/Appropriations
S.2976/H.R.5961 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY'19 (APHIS, FDA, and Foreign Market Development Program) H.R.1625 - Consolidated Appropriations Act of 2018 (Antibiotics and Animal Health) - no specific legislation S.2434/H.R.5554 - Animal Drug and Animal Generic Drug User Fee Amendments of 2018
Client expense: Not reported · Firm income: $20,000
Government targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE
2018 · second_quarter · Animals
Codex Alimentarius Commission (Animal Health Issues) Issues related to animal health and food safety - no specific legislation Implementation of biotechnology policy - no specific legislation Issues related to animal health, antibiotics, and food safety - no specific legislation Issues related to animal biologics - no specific legislation Issues related to antibiotics and medical treatment - no specific legislation Issues related to National Environmental Policy Act (implementing procedures - no specific legislation S.2434 - Animal Drug and Animal Generic Drug User Fee Amendments 2018
Client expense: Not reported · Firm income: $50,000
Government targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
2018 · second_quarter · Budget/Appropriations
S.2976/H.R.5961 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY'19 (APHIS and FDA) S.1839/H.R.2321 - CREAATE Act S.2434/H.R.5554 - Animal Drug and Animal Generic Drug User Fee Amendments of 2018
Client expense: Not reported · Firm income: $50,000
Government targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
2018 · second_quarter · Health Issues
Issues related to Over the Counter (OTC) Monograph reform, influenza, and drug pricing; S.2852, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018; S.2434, Animal Drug and Animal Generic Drug User Fee Amendments of 2018.
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · second_quarter · Pharmacy
H.R. 5472/S. 2651 Fairness to Pet Owners Act HR 5554/S.2434 Animal Drug and Animal Generic Drug User Fee Amendments Act of 2018 S. 2680, Opioid crisis response act of 2018; provisions related to veterinary access to controlled substances for veterinary use, as prescribers and DEA registrants H.R. 6, Support for Patients and Communities Act, provisions related to veterinary access to controlled substances for veterinary use, as prescribers and DEA registrants
Client expense: $200,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Education, Dept of, HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), Office of Management & Budget (OMB), SENATE, Transportation, Dept of (DOT), Treasury, Dept of
2018 · second_quarter · Health Issues
340B drug discount program; truthful non-misleading industry communications; compassionate use/right to try; importation of biopharmaceuticals; drug pricing; transparency; H.R.2051, FAST Generics Act of 2017; H.R.878, Trickett Wendler Right to Try Act of 2017/S.204, Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017 (P.L.115-176); TRICARE issues in H.R.5515/S.2987, National Defense Authorization Act for Fiscal Year 2019; S.2434, Animal Drug and Animal Generic Drug User Fee Amendments of 2018; S.2852, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018.
Client expense: Not reported · Firm income: $50,000
Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
2018 · second_quarter · Health Issues
Issues related to health care, the Food and Drug Administration (FDA), the 340B Program, animal health, drug pricing, and oncology coverage; Vaccine provisions and TRICARE Pilot Program in H.R.5515/S.2987, National Defense Authorization Act for Fiscal Year 2019; Implementation of P.L.114-255, 21st Century Cures Act; H.R.878, Trickett Wendler Right to Try Act of 2017/S.204, Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017 (P.L.115-176); S.2434, Animal Drug and Animal Generic Drug User Fee Amendments of 2018; S.2852, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018.
Client expense: Not reported · Firm income: $40,000
Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
2018 · second_quarter · Food Industry (safety, labeling, etc.)
S.221 Common Sense Nutrition Disclosure Act of 2017 (menu labeling); H.R.1687 Sweet Act (sugary beverages); S.3042 & H.R.2 Farm bill 2018; H.R.5425 Food Labeling Modernization Act and Food Allergen Labeling and Consumer Protection Act; S.2434 & H.R.5554 Animal Drug User Fees Act; S.3099 Strengthening Antibiotic Oversight Act; S.1113 Modernization of Cosmetics Regulation Act
Client expense: $10,000 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2018 · second_quarter · Animals
HR 5554 and S 2434, Animal Drug User Fee Act HR 4577, The Domestic Explosives Detection Canine Capacity Building Act of 2017
Client expense: $50,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Labor, Dept of (DOL), SENATE
2018 · second_quarter · Telecommunications
Issues specific to wireless policy, including but not limited to spectrum policy, cyber security, privacy, data breach, infrastructure and tax related issues. S. 19, the Mobile Now Act, S. 1104; Rural Wireless Access Act; H.R 3347, Viewers Protection Act; S. 1632, Viewer and Listener Protection Act; S. 1682, the AIRWAVES Act. S.2434, Precision Agriculture Connectivity Act, HR 4881; S. 2391, Defending U.S. Gov't Communications Act; SJ Res 52, Resolution Reinstating Internet Freedom; S. 1988, SPEED Act; H.R. 6017 and S. 3010. the SPECTRUM NOW ACT
Client expense: Not reported · Firm income: $67,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · second_quarter · Animals
Animal Drug User Fee Act/Animal Generic User Fee Act S 2434, Animal Food Ingredient Amendments
Client expense: $20,000 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE